Form 4: Bridgewater Bancshares Inc. Executive Laura Espeseth Reports Stock Option Grant
SEC Form 4 Filing
Laura Espeseth, Chief Accounting Officer of Bridgewater Bancshares Inc., reports the grant of stock options.
Summary
- Laura Espeseth, Chief Accounting Officer of Bridgewater Bancshares Inc., filed a Form 4 detailing changes in beneficial ownership.
- The report indicates the grant of an option to buy 25,000 shares of common stock at an exercise price of $13.78 on February 3, 2025, exercisable in 25% increments over four years.
- The report also lists existing options to buy common stock granted under previous incentive plans.
Sentiment
Score: 7
Explanation: The sentiment is neutral to slightly positive. It reflects standard executive compensation practices and aligns management with shareholder interests. There are no indications of negative events or concerns.
Positives
- The grant of stock options aligns the executive's interests with those of the shareholders.
- The vesting schedule encourages long-term commitment from the executive.
Future Outlook
The document does not contain specific forward-looking statements, but the option grant suggests an expectation of future value creation.
Industry Context
Stock option grants are a common form of executive compensation in the banking industry, aligning management's interests with shareholder value.
Comparison to Industry Standards
- Stock option grants are a standard component of executive compensation packages in the financial services industry.
- Comparable companies like TCF Financial (now Huntington Bancshares) and Old National Bancorp also utilize stock options as part of their executive compensation plans.
- The vesting schedules and exercise prices are generally aligned with industry norms to incentivize long-term performance.
Stakeholder Impact
- The stock option grant could positively impact shareholders by incentivizing the executive to improve company performance.
- Employees may view the grant as a positive sign of the company's commitment to its leadership.
Key Dates
| Date | Description |
|---|---|
| 10/01/2017 | Date of grant for option exercisable in 20% increments on the first five anniversaries. |
| 09/01/2018 | Date of grant for option exercisable in 20% increments on the first five anniversaries. |
| 08/01/2023 | Date of grant for option exercisable in 25% increments on the first four anniversaries. |
| 02/03/2025 | Date of the latest transaction: grant of option to buy 25,000 shares. |
| 02/04/2025 | Date of Form 4 filing. |
| 02/03/2035 | Expiration date of the option granted on 02/03/2025. |
Keywords
stock options, Form 4, Bridgewater Bancshares, beneficial ownership, insider trading, equity incentive plan, Laura Espeseth
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.